Pure Global

COVID-19 Quick Start - Test and Treat in Africa - Trial NCT06360783

Access comprehensive clinical trial information for NCT06360783 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Recruitment Completed. The study focuses on COVID-19. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06360783
Recruitment Completed
Trial Details
ClinicalTrials.gov โ€ข NCT06360783
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
COVID-19 Quick Start - Test and Treat in Africa
Evaluation of a COVID-19 Quick Start Test and Treat Model in Africa

Study Focus

COVID-19

Observational

Sponsor & Location

Duke University

Durham, United States of America

Timeline & Enrollment

N/A

Feb 01, 2023

Jun 01, 2024

1000 participants

Primary Outcome

Stakeholder Perspectives

Summary

Duke University and the Clinton Health Access Initiative (CHAI), in partnership with the
 Ministries of Health (MoH) of Ghana, Malawi, Rwanda, Zambia, and Zimbabwe, aim to assess the
 implementation and impact of COVID-19 test -and -treat (T&T) demonstration programs

ICD-10 Classifications

COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Viral infection, unspecified
Rift Valley fever

Data Source

ClinicalTrials.gov

NCT06360783

Non-Device Trial